Diagnostics test reagent/ kits for Dengue Combo .-Dengue Combo Test is a lateral flow assay for the qualitative detection of dengue NS1 antigen and IgG and IgM antibodies in human Serum/Plasma Samples.,anti-Treponema pallidum antibodies
- UID
- MFG/IVD/2022/000009_7e62d9d5cafd4188cf629abe42f412a8_84ad79380bac87b3fd751d7fd7dd084e
- Device class
- Class C
- Brand name
- Covid-19 RT PCR
- License holder
- Vimek Bioconcept Pvt Ltd
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- In-vitro Diagnostic reagent kit for specific hemagglutination test for the qualitative and semi-quantitative detection of anti-T.pallidum antibodies in human serum
Diagnostics test reagent/ kits for Dengue Combo .-Dengue Combo Test is a lateral flow assay for the qualitative detection of dengue NS1 antigen and IgG and IgM antibodies in human Serum/Plasma Samples.,anti-Treponema pallidum antibodies is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000009_7e62d9d5cafd4188cf629abe42f412a8_84ad79380bac87b3fd751d7fd7dd084e. This device is marketed under the brand name Covid-19 RT PCR. The license holder is Vimek Bioconcept Pvt Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.